Form 4: Recursion Pharmaceuticals Director Acquires Shares Under Compensation Policy

Director Terry-Ann Burrell acquired 1,843 shares of Recursion Pharmaceuticals' Class A Common Stock on July 1, 2024, under the company's Outside Director Compensation Policy.

Summary

• On July 1, 2024, Terry-Ann Burrell, a director of Recursion Pharmaceuticals, acquired 1,843 shares of Class A Common Stock.
• The acquisition was made under the Issuer's Outside Director Compensation Policy.
• Following the transaction, Burrell directly owns 71,254 shares of Recursion Pharmaceuticals.
• The transaction was reported on July 3, 2024.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a routine transaction under a pre-existing compensation policy. It doesn't necessarily indicate a strong positive or negative outlook.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The Outside Director Compensation Policy aligns director interests with shareholder interests.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gauge insider sentiment about the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates